[Pro and contra: basic precedence of atypical neuroleptics].
Naber
Dieter
D
Universitätsklinikum Hamburg-Eppendorf, Klinik für Psychiatrie und Psychotherapie. naber@uke.uni-hamburg.de
Dose
Matthias
M
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000145:classification* / Q000191:economics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016527:Drug Costs / Q000706:statistics & numerical data; D011307:Drug Prescriptions / Q000191:economics / Q000706:statistics & numerical data; D005858:Germany; D006801:Humans; D009313:National Health Programs / Q000191:economics; D017410:Practice Guidelines as Topic; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000191:economics; D016896:Treatment Outcome
D014150:Antipsychotic Agents